Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands.
暂无分享,去创建一个
Wei Sun | Sun Choi | Larry V. Pearce | Peter M. Blumberg | Minghua Cui | Suyoung Yoon | Jeewoo Lee | Karam Son | Timothy E. Esch | Myeong Seop Kim | Sung-Eun Kim | Hyeung-Geun Park | Yooran Ki | Song Yeon Ahn | Ian A. DeAndrea-Lazarus
[1] Y. Nagao,et al. Efficient synthesis of isothiocyanates based on the tandem Staudinger/aza-Wittig reactions and mechanistic consideration of the tandem reactions. , 2006, Chemical & pharmaceutical bulletin.
[2] Koen Van Laere,et al. Synthesis and biological evaluation of [¹¹C]SB366791: a new PET-radioligand for in vivo imaging of the TRPV1 receptor. , 2013, Nuclear medicine and biology.
[3] Dong Wook Kang,et al. Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies , 2011, J. Comput. Aided Mol. Des..
[4] P. Blumberg,et al. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper , 1989, Neuroscience.
[5] S. Y. Kim,et al. Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding. , 2004, Bioorganic & medicinal chemistry.
[6] A. Basbaum,et al. The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing Stimuli , 1998, Neuron.
[7] Dong Wook Kang,et al. 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region. , 2012, Journal of medicinal chemistry.
[8] A. Szallasi,et al. Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine. , 1997, Life sciences.
[9] P. Blumberg,et al. Vanilloid (Capsaicin) receptors and mechanisms. , 1999, Pharmacological reviews.
[10] Ji-Min Kim,et al. N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor. , 2003, Journal of medicinal chemistry.
[11] Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism. , 2012, Bioorganic & medicinal chemistry letters.
[12] S. Hwang,et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Blumberg,et al. N-(3-Acyloxy-2-benzylpropyl)-N'-(4-hydroxy-3-methoxybenzyl) thiourea derivatives as potent vanilloid receptor agonists and analgesics. , 2001, Bioorganic & medicinal chemistry.
[14] Jiyoun Lee,et al. High affinity antagonists of the vanilloid receptor. , 2002, Molecular pharmacology.
[15] D. Julius,et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide , 1999, Nature.
[16] John N. Wood,et al. Capsaicin in the study of pain , 1993 .
[17] D. Julius,et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.
[18] Dong Wook Kang,et al. Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues. , 2008, Journal of medicinal chemistry.